These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry. Daniels CJ; Rajpal S; Greenshields JT; Rosenthal GL; Chung EH; Terrin M; Jeudy J; Mattson SE; Law IH; Borchers J; Kovacs R; Kovan J; Rifat SF; Albrecht J; Bento AI; Albers L; Bernhardt D; Day C; Hecht S; Hipskind A; Mjaanes J; Olson D; Rooks YL; Somers EC; Tong MS; Wisinski J; Womack J; Esopenko C; Kratochvil CJ; Rink LD; JAMA Cardiol; 2021 Sep; 6(9):1078-1087. PubMed ID: 34042947 [TBL] [Abstract][Full Text] [Related]
5. COVID and Cardiovascular Disease: What We Know in 2021. Chilazi M; Duffy EY; Thakkar A; Michos ED Curr Atheroscler Rep; 2021 May; 23(7):37. PubMed ID: 33983522 [TBL] [Abstract][Full Text] [Related]
6. Implications of SARS-CoV-2-Associated Myocarditis in the Medical Evaluation of Athletes. Raukar NP; Cooper LT Sports Health; 2021 Mar; 13(2):145-148. PubMed ID: 33201768 [TBL] [Abstract][Full Text] [Related]
7. Low prevalence of cardiac abnormalities in competitive athletes at return-to-play after COVID-19. Maestrini V; Penza M; Filomena D; Birtolo LI; Monosilio S; Lemme E; Squeo MR; Mango R; Di Gioia G; Serdoz A; Fiore R; Fedele F; Pelliccia A; Di Giacinto B J Sci Med Sport; 2023 Jan; 26(1):8-13. PubMed ID: 36372623 [TBL] [Abstract][Full Text] [Related]
9. Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study-the CARDOVID registry. Aeschlimann FA; Misra N; Hussein T; Panaioli E; Soslow JH; Crum K; Steele JM; Huber S; Marcora S; Brambilla P; Jain S; Navallas M; Giuli V; Rücker B; Angst F; Patel MD; Azarine A; Caro-Domínguez P; Cavaliere A; Di Salvo G; Ferroni F; Agnoletti G; Bonnemains L; Martins D; Boddaert N; Wong J; Pushparajah K; Raimondi F J Cardiovasc Magn Reson; 2021 Dec; 23(1):140. PubMed ID: 34969397 [TBL] [Abstract][Full Text] [Related]
10. Is cardiac involvement prevalent in highly trained athletes after SARS-CoV-2 infection? A cardiac magnetic resonance study using sex-matched and age-matched controls. Szabó L; Juhász V; Dohy Z; Fogarasi C; Kovács A; Lakatos BK; Kiss O; Sydó N; Csulak E; Suhai FI; Hirschberg K; Becker D; Merkely B; Vágó H Br J Sports Med; 2022 May; 56(10):553-560. PubMed ID: 34848398 [TBL] [Abstract][Full Text] [Related]
11. Review on Cardiorespiratory Complications after SARS-CoV-2 Infection in Young Adult Healthy Athletes. Romagnoli S; Sbrollini A; Marcantoni I; Morettini M; Burattini L Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35565074 [TBL] [Abstract][Full Text] [Related]
12. Catecholamines Are the Key Trigger of COVID-19 mRNA Vaccine-Induced Myocarditis: A Compelling Hypothesis Supported by Epidemiological, Anatomopathological, Molecular, and Physiological Findings. Cadegiani FA Cureus; 2022 Aug; 14(8):e27883. PubMed ID: 35971401 [TBL] [Abstract][Full Text] [Related]
13. A prospective study on the consequences of SARS-CoV-2 infection on the heart of young adult competitive athletes: Implications for a safe return-to-play. Cavigli L; Frascaro F; Turchini F; Mochi N; Sarto P; Bianchi S; Parri A; Carraro N; Valente S; Focardi M; Cameli M; Bonifazi M; D'Ascenzi F Int J Cardiol; 2021 Aug; 336():130-136. PubMed ID: 34082008 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Magnetic Resonance for Patients With COVID-19. Petersen SE; Friedrich MG; Leiner T; Elias MD; Ferreira VM; Fenski M; Flamm SD; Fogel M; Garg R; Halushka MK; Hays AG; Kawel-Boehm N; Kramer CM; Nagel E; Ntusi NAB; Ostenfeld E; Pennell DJ; Raisi-Estabragh Z; Reeder SB; Rochitte CE; Starekova J; Suchá D; Tao Q; Schulz-Menger J; Bluemke DA JACC Cardiovasc Imaging; 2022 Apr; 15(4):685-699. PubMed ID: 34656482 [TBL] [Abstract][Full Text] [Related]
15. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Patone M; Mei XW; Handunnetthi L; Dixon S; Zaccardi F; Shankar-Hari M; Watkinson P; Khunti K; Harnden A; Coupland CAC; Channon KM; Mills NL; Sheikh A; Hippisley-Cox J Nat Med; 2022 Feb; 28(2):410-422. PubMed ID: 34907393 [TBL] [Abstract][Full Text] [Related]
17. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
18. Findings From Cardiovascular Evaluation of National Collegiate Athletic Association Division I Collegiate Student-Athletes After Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection. Hwang CE; Kussman A; Christle JW; Froelicher V; Wheeler MT; Moneghetti KJ Clin J Sport Med; 2022 Mar; 32(2):103-107. PubMed ID: 34173780 [TBL] [Abstract][Full Text] [Related]
19. Cardiac screening before returning to elite sport after SARS-CoV-2 infection. Hédon C; Schnell F; Sosner P; Chagué F; Schuster I; Julia M; Duparc A; Guy JM; Molinari N; Michaux L; Cransac F; Cade S Arch Cardiovasc Dis; 2022 Nov; 115(11):562-570. PubMed ID: 36207245 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical implications of persistent or exertional cardiopulmonary symptoms following SARS-CoV-2 infection in 3597 collegiate athletes: a study from the Outcomes Registry for Cardiac Conditions in Athletes (ORCCA). Petek BJ; Moulson N; Baggish AL; Kliethermes SA; Patel MR; Churchill TW; Harmon KG; Drezner JA; Br J Sports Med; 2022 Aug; 56(16):913-918. PubMed ID: 34725052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]